Current filters:

North America

1876 to 1885 of 3010 results

Alimera resubmits eye drug Iluvien to US regulator


USA-based Alimera Sciences (Nasdaq: ALIM) says that it has resubmitted its New Drug Application for Iluvien…

Alimera SciencesIluvienNorth AmericaOphthalmicsPharmaceuticalpSividaRegulation

US FDA clears first hep C drug in a decade, Merck & Co’s Victrelis


In much awaited, though largely expected news, the US Food and Drug Administration on Friday approved…

Anti-viralsboceprevirMerck & CoNorth AmericaPharmaceuticalRegulationtelaprevirVertexVictrelis

US Medicare likely to run out of funds in 2024; Congressional Affordable Medicines Caucus


The US Trustees of the Social Security and Medicare trust funds report on the current and projected financial…

GenericsHealthcareNorth AmericaPharmaceuticalPoliticsPricing

Roche files for US and EU approval of vemurafenib for metastatic skin cancer


US biotech giant Genentech, part of Swiss drug major Roche (SIX: ROG), has submitted a New Drug Application…

Bristol-Myers SquibbDaiichi SankyoEuropeGenentechNorth AmericaOncologyPharmaceuticalPlexxikonRegulationRochevemurafenibYervoy

US concerns about bias in commercially funded continuing medical education


Commercial funding of continuing medical education (CME) and the potential for bias appear to concern…

North AmericaPharmaceuticalResearch

US FTC warns Sanofi, Watson and Synthon over Ambien patent deal, but won’t take action


The Federal Trade Commission’s Bureau of Competition has notified Sanofi-Aventis US, a subsidiary…

AmbienGenericsLegalNorth AmericaPatentsPharmaceuticalSanofi-AventisSynthonWatson Pharmaceuticals

US appros of biotech drugs nearly doubled in last decade, says Tufts CSDD


US regulatory approvals for new biopharmaceuticals nearly doubled in the last decade, compared to the…

BiotechnologyNorth AmericaRegulation

1876 to 1885 of 3010 results

Back to top